Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: United Therapeutics Corporation, 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
United Therapeutics Corporation June 26, 202690.2%
-
United Therapeutics Corporation June 26, 202588.6%
-
United Therapeutics Corporation June 26, 202489.4%
-
United Therapeutics Corporation June 26, 202390.1%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 9, 2026 | United Therapeutics Corporation | Option exercise | +1,210 | $132.30 | $160,083 |
| Nov 9, 2026 | United Therapeutics Corporation | Open-market sale | −1,210 | $580.00 | $701,800 |
| Jul 9, 2026 | United Therapeutics Corporation | Option exercise | +650 | — | — |
| Apr 24, 2026 | United Therapeutics Corporation | Option exercise | +2,910 | $101.80 | $296,238 |
| Apr 24, 2026 | United Therapeutics Corporation | Open-market sale | −2,910 | $569.00 | $1,655,790 |
| Apr 17, 2026 | United Therapeutics Corporation | Option exercise | +1,000 | $101.80 | $101,800 |
| Apr 17, 2026 | United Therapeutics Corporation | Open-market sale | −1,000 | $578.88 | $578,880 |
| Dec 15, 2025 | United Therapeutics Corporation | Option exercise | +1,000 | $101.80 | $101,800 |
| Dec 15, 2025 | United Therapeutics Corporation | Open-market sale | −1,000 | $495.95 | $495,950 |
| Jul 25, 2025 | United Therapeutics Corporation | Option exercise | +590 | — | — |
| Mar 19, 2025 | United Therapeutics Corporation | Option exercise | +5,000 | $175.43 | $877,150 |
| Mar 19, 2025 | United Therapeutics Corporation | Open-market sale | −300 | $307.73 | $92,319 |
| Mar 19, 2025 | United Therapeutics Corporation | Open-market sale | −1,780 | $308.82 | $549,700 |
| Mar 19, 2025 | United Therapeutics Corporation | Open-market sale | −328 | $309.73 | $101,591 |
| Mar 19, 2025 | United Therapeutics Corporation | Open-market sale | −457 | $310.80 | $142,036 |
Questions about Christopher Patusky
What boards is Christopher Patusky on?
Christopher Patusky sits on the board of United Therapeutics Corporation.
How long has Christopher Patusky served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.